MRK vs CVS
By Alex · Tickerpine
Merck & Co., Inc. vs CVS Health Corporation, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MRK | CVS |
|---|---|---|
| Price | $147.76 | $89.35 |
| Market cap | $364.26B | $114.32B |
| P/E ratio | 149.3 | 10.4 |
| ROE | 5.06% | 14.36% |
| Profit margin | 3.64% | 2.64% |
| Revenue growth | 4.70% | 5.40% |
| Dividend yield | 2.30% | 2.98% |
| Beta | 0.12 | 0.58 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MRK vs CVS in plain English
- MRK is the bigger company — about 3.2× the market cap of CVS.
- CVS is cheaper on earnings (P/E 10.4 vs 149.3).
- CVS earns a higher return on equity (14% vs 5%).
- CVS is growing revenue faster (5% vs 5%).
- CVS has the higher dividend yield (2.98% vs 2.30%).
How would $1,000 have done in each?
MRK return calculator
See what $1,000 in Merck & Co., Inc. would be worth today.
CVS return calculator
See what $1,000 in CVS Health Corporation would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.